Structures by: Moore C.
Total: 163
TW-2-13 [2-(2-pyridyl)-imidazole]3, I-(CF2)6-I
(C8H7N3)3(C6F12I2)
CrystEngComm (2014) 16, 31 7218
a=5.1393(6)Å b=11.0259(12)Å c=15.2795(17)Å
α=92.084(3)° β=91.221(3)° γ=100.093(3)°
TW-1-68 [2-(2-pyridyl)-imidazole]2, 4,4'-diiodo-F8-biphenyl
(C8H7N3)2(C12F8I2)
CrystEngComm (2014) 16, 31 7218
a=24.4359(12)Å b=7.2667(4)Å c=16.3695(8)Å
α=90.00° β=109.7130(10)° γ=90.00°
TW-1-R38 2-(2-pyridyl)-imidazole, 1,4-diiodotetrafluorobenzene
(C8H7N3)(C6F4I2)
CrystEngComm (2014) 16, 31 7218
a=9.3920(5)Å b=10.5244(6)Å c=17.4011(10)Å
α=106.841(2)° β=92.190(2)° γ=106.005(2)°
TW-2-09 2-(2-pyrazinyl)-imidazole, I-(CF2)4-I
(C7H6N4)2(C4F8I2)
CrystEngComm (2014) 16, 31 7218
a=6.1488(7)Å b=6.3967(7)Å c=15.8942(19)Å
α=81.861(4)° β=85.950(4)° γ=72.388(3)°
TW-1-M1 2-(2-pyrazinyl)-imidazole, 1,4-diiodotetrafluorobenzene, I-(CF2)4-I
(C7H6N4)2(C6F4I2)
CrystEngComm (2014) 16, 31 7218
a=11.0717(6)Å b=10.6250(6)Å c=10.1858(6)Å
α=90.00° β=108.814(2)° γ=90.00°
TW-1-59 [2-(2-pyrazinyl)-imidazole]2, 1,3,5-F3-2,4,6-I3-benzene
(C7H6N4)2(C6F3I3)
CrystEngComm (2014) 16, 31 7218
a=33.0655(16)Å b=9.8284(5)Å c=7.3176(3)Å
α=90.00° β=90.00° γ=90.00°
TW-1-69 [2-(2-pyrazinyl)-imidazole]2, 4,4'-diiodo-F8-biphenyl
(C7H6N4)2(C12F8I2)
CrystEngComm (2014) 16, 31 7218
a=7.6527(4)Å b=12.7331(7)Å c=15.4446(9)Å
α=67.3200(10)° β=88.558(2)° γ=81.6160(10)°
C6F4I2,2(C8H7N3)
C6F4I2,2(C8H7N3)
CrystEngComm (2014) 16, 31 7218
a=10.0009(13)Å b=28.964(4)Å c=4.1036(6)Å
α=90.00° β=100.997(2)° γ=90.00°
(2,2'-biphenyl)(4,4'-dibromo-2,2'-bipyridyl)platinum(II)
C22H14Br2N2Pt
Dalton transactions (Cambridge, England : 2003) (2015) 44, 39 17075-17090
a=7.2532(17)Å b=20.093(4)Å c=24.757(6)Å
α=90° β=90° γ=90°
2,2'-biphenyl)(4,4'-dimethyl-2,2'-bipyridyl)platinum(II)
C24H20N2Pt,C3H6O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 39 17075-17090
a=13.8433(10)Å b=9.9922(7)Å c=17.0754(13)Å
α=90° β=112.027(3)° γ=90°
(2,2'-biphenyl)(4,4'-diethylester-2,2'-dipyridyl)platinum(II)
C28H24N2O4Pt
Dalton transactions (Cambridge, England : 2003) (2015) 44, 39 17075-17090
a=22.3019(11)Å b=7.1519(4)Å c=31.0906(15)Å
α=90° β=105.466(3)° γ=90°
Tyr-D-Tic
C19H20N2O4,1.5H2O
Acta Crystallographica Section C (1997) 53, 10 1478-1482
a=9.1270(10)Å b=10.5220(10)Å c=37.195(2)Å
α=90.00° β=90.00° γ=90.00°
Tyr-D-Tic-NH2
C19H21N3O3,H2O
Acta Crystallographica Section C (1997) 53, 10 1478-1482
a=8.9810(10)Å b=10.597Å c=9.7030(10)Å
α=90.00° β=98.760(10)° γ=90.00°
4-Acetylresorcinol
C8H8O3
Acta Crystallographica Section E (2007) 63, 11 o4252-o4252
a=7.1325(3)Å b=13.7067(5)Å c=7.2998(3)Å
α=90.00° β=92.369(2)° γ=90.00°
9-Oxo-4,5-diazoniafluorene sulfate
C11H8N2O12,SO42
Acta Crystallographica Section E (2007) 63, 9 o3740-o3740
a=11.9016(12)Å b=11.9344(12)Å c=7.8351(7)Å
α=90.00° β=90.00° γ=90.00°
<i>fac</i>-Aqua(bipyrazine)tricarbonylrhenium(I) hexafluorophosphate dihydrate
C11H8N4O4Re,F6P,2H2O
Acta Crystallographica Section E (2007) 63, 5 m1404-m1405
a=15.5869(6)Å b=13.1068(5)Å c=9.0349(4)Å
α=90.00° β=90.00° γ=90.00°
4b,5,7,7a-Tetrahydro-4b,7a-epiminomethanoimino-6H- imidazo[4,5-f][1,10]phenanthroline-6,13-dione monohydrate
C14H10N6O2,H2O
Acta Crystallographica Section E (2007) 63, 8 o3526-o3526
a=18.5164(18)Å b=12.3920(12)Å c=12.6929(13)Å
α=90.00° β=108.528(5)° γ=90.00°
2-Chloro-4-(1<i>H</i>-pyrazol-1-yl)-5-(trifluoromethyl)pyrimidine
C8H4ClF3N4
Acta Crystallographica Section E (2010) 66, 6 o1448
a=5.5776(3)Å b=7.7117(4)Å c=21.8335(12)Å
α=90.00° β=90.00° γ=90.00°
(3a<i>S</i>,7a<i>S</i>)-5-[(<i>S</i>)-3,3,3-Trifluoro-2-methoxy-2- phenylpropanoyl]-2,3,4,5,6,7-hexahydro-1<i>H</i>- pyrrolo[3,4-<i>c</i>]pyridin-3(2<i>H</i>)-one monohydrate
C17H19F3N2O3,H2O
Acta Crystallographica Section E (2010) 66, 1 o175-o176
a=8.4870(4)Å b=13.7152(7)Å c=14.9113(7)Å
α=90.00° β=90.00° γ=90.00°
2-(6-Bromo-3-pyridyl)-8-methylimidazo[1,2-<i>a</i>]pyrazine
C12H9BrN4
Acta Crystallographica Section E (2010) 66, 7 o1723
a=3.9007(14)Å b=13.545(5)Å c=20.673(8)Å
α=90.00° β=93.059(5)° γ=90.00°
Carbonyl[tris(3,5-diphenylpyrazol-1-yl-κ<i>N</i>^2^)methane]copper(I) hexafluoridophosphate—–dichloromethane—–diethyl ether (4/3/1)
C47H34CuN6O1,F6P,0.75(CH2Cl2),0.25(C4H10O1)
Acta Crystallographica Section E (2009) 65, 11 m1354-m1355
a=19.891(3)Å b=13.772(2)Å c=16.091(3)Å
α=90.00° β=93.847(2)° γ=90.00°
<i>catena</i>-Poly[[[bis(<i>N</i>,<i>N</i>-dimethylformamide)iron(II)]- {μ-2,2-bis(diphenylphosphinoyl)-<i>N</i>,<i>N</i>'-[(1<i>R</i>,2<i>R</i>)- cyclohexane-1,2-diyl]dibenzamide}] bis(perchlorate) <i>N</i>,<i>N</i>-dimethylformamide disolvate]
C50H54FeN4O6P22,2(ClO4),2(C3H7NO)
Acta Crystallographica Section E (2009) 65, 12 m1512-m1513
a=10.9725(4)Å b=15.4417(6)Å c=36.2173(14)Å
α=90.00° β=90.00° γ=90.00°
5-Bromo-1<i>H</i>-thieno[2,3-<i>d</i>]imidazole
C5H3Br1N2S1
Acta Crystallographica Section E (2010) 66, 8 o2021
a=3.8917(11)Å b=17.118(5)Å c=9.405(3)Å
α=90.00° β=91.359(3)° γ=90.00°
5-Bromo-3-(indan-1-yloxy)pyridin-2-amine
C14H13BrN2O
Acta Crystallographica Section E (2011) 67, 3 o650
a=11.3944(18)Å b=9.4515(15)Å c=12.438(2)Å
α=90.00° β=110.678(2)° γ=90.00°
C27H33BF2I2N2O
C27H33BF2I2N2O
Langmuir : the ACS journal of surfaces and colloids (2015) 31, 35 9707-9717
a=9.0317(6)Å b=11.6572(9)Å c=13.7558(12)Å
α=99.386(3)° β=101.188(3)° γ=102.814(3)°
C24H51NO5
C24H51NO5
Journal of the American Chemical Society (2009) 131, 13548-13554
a=19.615(2)Å b=16.4013(16)Å c=17.4466(18)Å
α=90.00° β=99.925(2)° γ=90.00°
C28H57NO4
C28H57NO4
Journal of the American Chemical Society (2009) 131, 13548-13554
a=13.0950(10)Å b=13.9148(10)Å c=16.7377(12)Å
α=90.00° β=96.2900(10)° γ=90.00°
C28H57O4P
C28H57O4P
Journal of the American Chemical Society (2009) 131, 13548-13554
a=13.0862(11)Å b=15.4546(13)Å c=15.2946(13)Å
α=90.00° β=96.1360(10)° γ=90.00°
C24H54CaO14
C24H54CaO14
Journal of the American Chemical Society (2009) 131, 13548-13554
a=6.4772(6)Å b=14.4843(13)Å c=17.5838(15)Å
α=90.00° β=92.390(2)° γ=90.00°
C24H48Cs2O11
C24H48Cs2O11
Journal of the American Chemical Society (2009) 131, 13548-13554
a=12.6808(7)Å b=16.7088(8)Å c=15.3231(7)Å
α=90.00° β=103.387(3)° γ=90.00°
C12H22O4
C12H22O4
Journal of the American Chemical Society (2009) 131, 13548-13554
a=35.5649(15)Å b=7.5143(3)Å c=10.3977(4)Å
α=90.00° β=106.706(3)° γ=90.00°
C16.5H23K2N1.5O5.75
C16.5H23K2N1.5O5.75
Journal of the American Chemical Society (2010) 132, 2099-2100
a=12.9463(13)Å b=13.1712(14)Å c=14.2459(15)Å
α=102.253(8)° β=106.079(8)° γ=95.609(8)°
C27.5H47.5KMnN7O4.5
C27.5H47.5KMnN7O4.5
Journal of the American Chemical Society (2011) 133, 5810-5817
a=15.687(4)Å b=20.310(5)Å c=25.983(7)Å
α=95.152(4)° β=92.776(4)° γ=106.600(4)°
C4HF2KO4
C4HF2KO4
Journal of the American Chemical Society (2012) 134, 7766-7772
a=4.6377(3)Å b=8.0574(6)Å c=15.4299(12)Å
α=90.00° β=90.00° γ=90.00°
NSoximeI 4-I-F4-PhCH=NOH
C7H2F4INO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.38850(10)Å b=6.00010(10)Å c=31.9307(7)Å
α=90.00° β=93.9030(10)° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, F5-benzaldehyde oxime
(C13H11N3)(C7H2F5NO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8616(8)Å b=7.6589(8)Å c=34.632(4)Å
α=90.00° β=90.00° γ=90.00°
NSoximeBr 4-Br-F4-PhCH=NOH
C7H2BrF4NO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.2896(3)Å b=5.9991(4)Å c=15.3706(10)Å
α=80.976(3)° β=84.419(4)° γ=88.344(3)°
MF-24-58 1-methyl-2-(4-pyridyl)benzimidazole, 4-Br-F4-PhCH=NOH
(C13H11N3)(C7H2F4NOBr)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8554(3)Å b=7.9485(4)Å c=34.9508(15)Å
α=90.00° β=90.00° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, 4-I-F4-PhCH=NOH
(C13H11N3)(C7H2F4INO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=7.2257(5)Å b=10.0969(8)Å c=13.7520(11)Å
α=81.535(6)° β=81.846(4)° γ=74.495(4)°
C22H30GeO2
C22H30GeO2
Inorganic Chemistry (2009) 48, 7510-7512
a=20.418(10)Å b=15.992(7)Å c=25.061(12)Å
α=90.00° β=90.00° γ=90.00°
C112H150Ge8N2O12
C112H150Ge8N2O12
Inorganic Chemistry (2009) 48, 7510-7512
a=14.531(9)Å b=15.160(9)Å c=27.040(16)Å
α=90.00° β=101.046(8)° γ=90.00°
C56H72Ge8O10
C56H72Ge8O10
Inorganic Chemistry (2009) 48, 7510-7512
a=12.5179(9)Å b=15.3810(11)Å c=17.2348(13)Å
α=68.3730(10)° β=77.7960(10)° γ=88.3800(10)°
2-amino-4-methyl-6-(3-pyridyl)pyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=6.9426(4)Å b=7.2048(5)Å c=9.3201(6)Å
α=92.459(4)° β=91.380(4)° γ=107.319(4)°
2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.5629(4)Å b=7.4679(6)Å c=22.1080(18)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine
C11H12N4O
Crystal Growth & Design (2007) 7, 11 2324
a=11.6368(8)Å b=7.2494(5)Å c=24.7339(17)Å
α=90.00° β=90.00° γ=90.00°
1-(2-aminopyrimidin-5-yl)-2-(pyrid-3-yl)ethyne
C12H9N3
Crystal Growth & Design (2007) 7, 11 2324
a=8.6286(6)Å b=15.3249(10)Å c=8.1780(6)Å
α=90.00° β=115.5070(10)° γ=90.00°
1-(6-amino-3-pyridyl)-2-(4-{benzimidazol-1-yl}phenyl) ethyne
C21H16N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.132(2)Å b=10.542(4)Å c=15.457(6)Å
α=83.343(19)° β=89.94(3)° γ=88.14(3)°
NS10b 2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=12.7944(9)Å b=12.9712(9)Å c=23.1035(15)Å
α=90.00° β=90.246(4)° γ=90.00°
1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, (CH2Cl2)0.5
(C13H12N4O)(C1H2CL2)0.5
Crystal Growth & Design (2007) 7, 11 2324
a=7.2432(8)Å b=7.7893(8)Å c=12.6950(13)Å
α=107.292(2)° β=91.059(2)° γ=98.566(2)°
C24H16N2Pt
C24H16N2Pt
Inorganic Chemistry (2013) 52, 596-607
a=10.1828(6)Å b=13.9182(8)Å c=12.8693(7)Å
α=90.00° β=112.509(3)° γ=90.00°
C23H18Cl2N2Pt
C23H18Cl2N2Pt
Inorganic Chemistry (2013) 52, 596-607
a=38.6769(7)Å b=38.6769(7)Å c=9.7217(4)Å
α=90.00° β=90.00° γ=90.00°
C13H10ClN4O3Re
C13H10ClN4O3Re
Inorganic chemistry (2007) 46, 16 6464-6472
a=27.1050(5)Å b=27.1050(5)Å c=11.2195(4)Å
α=90.00° β=90.00° γ=120.00°
C18.28H15F6N5.22O3PRe
C18.28H15F6N5.22O3PRe
Inorganic chemistry (2007) 46, 16 6464-6472
a=33.2103(3)Å b=33.2103(3)Å c=10.6556(2)Å
α=90.00° β=90.00° γ=120.00°
C16H11F6N5O3.5PRe
C16H11F6N5O3.5PRe
Inorganic chemistry (2007) 46, 16 6464-6472
a=8.3921(3)Å b=8.5622(3)Å c=14.5139(6)Å
α=90.727(2)° β=104.250(2)° γ=95.379(2)°
C11H6ClN4O3Re
C11H6ClN4O3Re
Inorganic chemistry (2007) 46, 16 6464-6472
a=6.4993(4)Å b=6.5962(4)Å c=15.2702(8)Å
α=101.790(2)° β=92.935(3)° γ=102.198(2)°
Silver(I)amidecyanoximate-bis(2-picolinate)
C15H16AgN5O2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 3 749-764
a=7.394(6)Å b=10.771(9)Å c=11.252(9)Å
α=90.187(9)° β=106.037(8)° γ=107.492(9)°
DW-3-8 (3-pyridyl)-CONH-(CH2)4-NHCO-(3-pyridyl), I-(CF2)4-I
(C14H14N4O2)(C4F8I2)
CrystEngComm (2014) 16, 44 10203
a=12.7557(6)Å b=9.5667(5)Å c=9.7394(5)Å
α=90.00° β=110.9880(10)° γ=90.00°
C24H56MgO15
C24H56MgO15
Journal of the American Chemical Society (2009) 131, 13548-13554
a=6.3954(7)Å b=31.990(3)Å c=16.2225(17)Å
α=90.00° β=97.990(4)° γ=90.00°
C24H33CuF18KO9
C24H33CuF18KO9
Organometallics (2013) 32, 12 3429
a=22.1068(11)Å b=8.5756(4)Å c=18.6294(9)Å
α=90.00° β=90.00° γ=90.00°
C27H15CuF18KO3
C27H15CuF18KO3
Organometallics (2013) 32, 12 3429
a=11.9365(6)Å b=22.8275(15)Å c=22.8784(11)Å
α=90.00° β=103.971(2)° γ=90.00°
C18H8CuF12O2,C12H24KO6
C18H8CuF12O2,C12H24KO6
Organometallics (2013) 32, 12 3429
a=8.6969(2)Å b=19.4441(3)Å c=10.5153(2)Å
α=90.00° β=105.3090(10)° γ=90.00°
C66H54Cu3F36K3O12
C66H54Cu3F36K3O12
Organometallics (2013) 32, 12 3429
a=25.3378(15)Å b=15.1435(9)Å c=23.1089(13)Å
α=90.00° β=118.6050(10)° γ=90.00°
2,2'-{[(2-Nitrobenzyl)azanediyl}bis(propane-3,1-diyl)}bis[1<i>H</i>-isoindole-1,3(2<i>H</i>)-dione]
C29H26N4O6
Acta Crystallographica Section E (2021) 77, 2 83-85
a=7.8576(10)Å b=12.3468(15)Å c=14.1147(17)Å
α=94.2950(10)° β=104.6030(10)° γ=101.0420(10)°